Letters
Surrogate end point scrutiny
A more evidence based approach to the use of surrogate end points in policy making
BMJ 2011; 343 doi: https://doi.org/10.1136/bmj.d6498 (Published 25 October 2011) Cite this as: BMJ 2011;343:d6498
- Oriana Ciani, PhD student1,
- Rod S Taylor, professor of health services research1
- 1Peninsula Technology Assessment Group (PenTAG), Peninsula College of Medicine and Dentistry, University of Exeter, Exeter EX2 4SG, UK
- oriana.ciani{at}pcmd.ac.uk
By retracing the history of particular surrogate outcome failures,1 Moynihan dismisses the assessment of surrogate outcomes in future clinical trials and instead recommends collecting only final outcomes such as survival.2 We agree that, when possible, decisions on the adoption and coverage of health technologies …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.